Coya Therapeutics (Coya Therapeutics) EV-to-Revenue : 20.21 (As of Jun. 12, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Coya Therapeutics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Coya Therapeutics's enterprise value is $123.90 Mil. Coya Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $6.13 Mil. Therefore, Coya Therapeutics's EV-to-Revenue for today is 20.21.

The historical rank and industry rank for Coya Therapeutics's EV-to-Revenue or its related term are showing as below:

COYA' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.54 Med: 12.27 Max: 16.68
Current: 20.21

During the past 4 years, the highest EV-to-Revenue of Coya Therapeutics was 16.68. The lowest was 5.54. And the median was 12.27.

COYA's EV-to-Revenue is ranked worse than
66.6% of 1033 companies
in the Biotechnology industry
Industry Median: 7.92 vs COYA: 20.21

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-12), Coya Therapeutics's stock price is $8.00. Coya Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.55. Therefore, Coya Therapeutics's PS Ratio for today is 14.47.

Coya Therapeutics EV-to-Revenue Historical Data

The historical data trend for Coya Therapeutics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coya Therapeutics EV-to-Revenue Chart

Coya Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

12.35

Coya Therapeutics Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial						-	-	-	12.35	17.78

Competitive Comparison of Coya Therapeutics's EV-to-Revenue

For the Biotechnology subindustry, Coya Therapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coya Therapeutics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coya Therapeutics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Coya Therapeutics's EV-to-Revenue falls into.

Coya Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Coya Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	123.897	/	6.129
	=	20.21

Coya Therapeutics's current Enterprise Value is $123.90 Mil.
Coya Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.13 Mil.

Coya Therapeutics (NAS:COYA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Coya Therapeutics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	8.00	/	0.553
	=	14.47

Coya Therapeutics's share price for today is $8.00.
Coya Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.55.

Coya Therapeutics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Coya Therapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Coya Therapeutics (Coya Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coya Therapeutics Inc (NAS:COYA) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5850 San Felipe Street, Suite 500, Houston, TX, USA, 77057

Website

https://www.coyatherapeutics.com

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Executives

Dieter Weinand	director	C/O REPLIMUNE GROUP, INC., 18 COMMERCE WAY, WOBURN MA 01801
Fred Grossman	officer: Chief Medical Officer	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Goldstein Dov A Md	director
Adrian Hepner	officer: Chief Medical Officer	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
David S Snyder	officer: Chief Financial Officer	ONE SCIENCE COURT, MADISON WI 53711
Hideki Garren	director	C/O PROTHENA BIOSCIENCES INC, 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Anabella Villalobos	director	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Howard Berman	director, 10 percent owner, officer: Chief Executive Officer	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Ann Lee	director	C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Bertex Llc	10 percent owner	5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057